![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 211/22 | (2006.01) |
A61K 31/426 | (2006.01) | ||
A61K 31/4439 | (2006.01) | ||
A61K 31/445 | (2006.01) | ||
A61K 31/451 | (2006.01) | ||
A61K 31/4535 | (2006.01) | ||
A61K 31/4545 | (2006.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/5375 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 1/12 | (2006.01) | ||
A61P 9/10 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 15/00 | (2006.01) | ||
A61P 17/06 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 25/04 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61P 25/32 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
C07D 211/20 | (2006.01) | ||
C07D 211/34 | (2006.01) | ||
C07D 265/30 | (2006.01) | ||
C07D 401/04 | (2006.01) | ||
C07D 401/06 | (2006.01) | ||
C07D 401/10 | (2006.01) | ||
C07D 401/14 | (2006.01) | ||
C07D 409/04 | (2006.01) | ||
C07D 409/10 | (2006.01) | ||
C07D 413/04 | (2006.01) | ||
C07D 417/04 | (2006.01) | ||
C07D 417/06 | (2006.01) |
(11) | Number of the document | 1140835 |
(13) | Kind of document | T |
(96) | European patent application number | 99956268.9 |
Date of filing the European patent application | 1999-12-01 | |
(97) | Date of publication of the European application | 2001-10-10 |
(45) | Date of publication and mention of the grant of the patent | 2004-05-12 |
(46) | Date of publication of the claims translation | 2004-08-25 |
(86) | Number | PCT/IB1999/001914 |
Date | 1999-12-01 |
(87) | Number | WO 2000/039091 |
Date | 2000-07-06 |
(30) | Number | Date | Country code |
114091 P | 1998-12-29 | US |
(72) |
LIRAS, Spiros, US
ALLEN, Martin, Patrick, US
SEGELSTEIN, Barbara, Eileen, US
|
(73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 3,3-Biarilpiperidino ir 2,2-biarilmorfolino dariniai |
3,3-BIARYLPIPERIDINE AND 2,2-BIARYLMORPHOLINE DERIVATIVES |
Payment date | Validity (years) | Amount | |
2004-10-28 | 6 | 480.00 LTL |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2005-12-01 |